contract research organizations
GPTKB entity
Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:organization
|
gptkbp:alsoKnownAs |
gptkb:CROs
|
gptkbp:associatedWith |
gptkb:Association_of_Clinical_Research_Organizations_(ACRO)
|
gptkbp:benefit |
cost reduction
increased efficiency access to expertise |
gptkbp:growthDriver |
cost pressures in pharma industry
globalization of drug development increasing complexity of clinical trials |
https://www.w3.org/2000/01/rdf-schema#label |
contract research organizations
|
gptkbp:industry |
medical device industry
biotechnology industry pharmaceutical industry |
gptkbp:notableClient |
gptkb:government_agency
foundations pharmaceutical companies biotechnology companies medical device companies |
gptkbp:notableExample |
gptkb:Covance
gptkb:IQVIA gptkb:PPD gptkb:Labcorp_Drug_Development gptkb:Medpace gptkb:Parexel gptkb:Charles_River_Laboratories gptkb:ICON_plc gptkb:Syneos_Health |
gptkbp:origin |
1970s
|
gptkbp:purpose |
outsourcing research services
|
gptkbp:region |
gptkb:Europe
gptkb:North_America gptkb:Asia-Pacific |
gptkbp:regulates |
gptkb:FDA
gptkb:EMA ICH guidelines |
gptkbp:service |
biostatistics
data management project management medical writing preclinical research regulatory affairs clinical trial management pharmacovigilance |
gptkbp:trend |
mergers and acquisitions
decentralized clinical trials adoption of digital technologies expansion into emerging markets |
gptkbp:市值 |
over $50 billion (2020s)
|
gptkbp:bfsParent |
gptkb:Pharmaceutical_Sciences
gptkb:EMA_Guidelines |
gptkbp:bfsLayer |
6
|